AMP Capital Investors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,900
| Closed | -$1.98M | – | 58 |
|
|
2022
Q1 | $1.98M | Buy |
+6,900
| New | +$1.78M | 0.08% | 68 |
|
|
2021
Q4 | – | Sell |
-219,598
| Closed | -$50.7M | – | 635 |
|
|
2021
Q3 | $50.7M | Sell |
219,598
-44,312
| -17% | -$10.9M | 0.28% | 84 |
|
|
2021
Q2 | $60.6M | Sell |
263,910
-29,655
| -10% | -$5.96M | 0.29% | 81 |
|
|
2021
Q1 | $54.8M | Sell |
293,565
-26,436
| -8% | -$5.17M | 0.27% | 87 |
|
|
2020
Q4 | $53.4M | Buy |
320,001
+15,151
| +5% | +$2.26M | 0.29% | 79 |
|
|
2020
Q3 | $44.6M | Buy |
304,850
+17,545
| +6% | +$2.72M | 0.26% | 93 |
|
|
2020
Q2 | $46.8M | Sell |
287,305
-13,880
| -5% | -$2.13M | 0.29% | 81 |
|
|
2020
Q1 | $41.7M | Sell |
301,185
-34,748
| -10% | -$4.77M | 0.31% | 75 |
|
|
2019
Q4 | $44.1M | Sell |
335,933
-86,281
| -20% | -$10M | 0.24% | 99 |
|
|
2019
Q3 | $47.4M | Sell |
422,214
-46,772
| -10% | -$5.21M | 0.26% | 92 |
|
|
2019
Q2 | $52.3M | Buy |
468,986
+68,018
| +17% | +$8.01M | 0.29% | 87 |
|
|
2019
Q1 | $51.7M | Sell |
400,968
-72,810
| -15% | -$8.85M | 0.29% | 87 |
|
|
2018
Q4 | $54.1M | Buy |
473,778
+14,577
| +3% | +$1.63M | 0.34% | 70 |
|
|
2018
Q3 | $49M | Sell |
459,201
-18,289
| -4% | -$1.83M | 0.27% | 88 |
|
|
2018
Q2 | $40.7M | Sell |
477,490
-32,686
| -6% | -$2.68M | 0.23% | 117 |
|
|
2018
Q1 | $39.3M | Buy |
510,176
+44,081
| +9% | +$3.55M | 0.22% | 116 |
|
|
2017
Q4 | $39.4M | Sell |
466,095
-20,113
| -4% | -$1.71M | 0.21% | 120 |
|
|
2017
Q3 | $41.6M | Sell |
486,208
-3,456
| -0.7% | -$283K | 0.23% | 108 |
|
|
2017
Q2 | $40.5M | Buy |
489,664
+21,393
| +5% | +$1.75M | 0.24% | 110 |
|
|
2017
Q1 | $39.7M | Buy |
468,271
+2,456
| +0.5% | +$197K | 0.24% | 104 |
|
|
2016
Q4 | $34.3M | Sell |
465,815
-28,587
| -6% | -$2.13M | 0.21% | 111 |
|
|
2016
Q3 | $39.4M | Sell |
494,402
-17,287
| -3% | -$1.38M | 0.24% | 93 |
|
|
2016
Q2 | $40M | Sell |
511,689
-657
| -0.1% | -$49.5K | 0.27% | 83 |
|
|
2016
Q1 | $36.8M | Buy |
512,346
+32,848
| +7% | +$2.49M | 0.25% | 97 |
|
|
2015
Q4 | $41.3M | Buy |
479,498
+7,480
| +2% | +$621K | 0.28% | 84 |
|
|
2015
Q3 | $37.9M | Buy |
472,018
+63,979
| +16% | +$5.4M | 0.28% | 86 |
|
|
2015
Q2 | $34.2M | Sell |
408,039
-155,629
| -28% | -$11.9M | 0.22% | 112 |
|
|
2015
Q1 | $41.6M | Buy |
563,668
+7,207
| +1% | +$513K | 0.25% | 94 |
|
|
2014
Q4 | $38.8M | Sell |
556,461
-34,566
| -6% | -$2.33M | 0.24% | 101 |
|
|
2014
Q3 | $38.6M | Sell |
591,027
-91,170
| -13% | -$5.77M | 0.24% | 102 |
|
|
2014
Q2 | $43M | Buy |
682,197
+100,245
| +17% | +$5.98M | 0.27% | 96 |
|
|
2014
Q1 | $33.5M | Sell |
581,952
-212,132
| -27% | -$11.8M | 0.23% | 102 |
|
|
2013
Q4 | $40.6M | Sell |
794,084
-185,556
| -19% | -$9.29M | 0.29% | 82 |
|
|
2013
Q3 | $49.5M | Sell |
979,640
-76,343
| -7% | -$4M | 0.38% | 56 |
|
|
2013
Q2 | $52.5M | Buy |
+1,055,983
| New | +$57.5M | 0.41% | 49 |
|
Other funds holding LLY
AMP Capital Investors's LLY Position: Q2 2022 in Review
AMP Capital Investors sold out of Eli Lilly (LLY) in Q2 2022, closing a stake of 6,900 shares — an estimated $1.98M sold.
AMP Capital Investors first reported a position in LLY in Q2 2013 and held it in 35 quarters. The position peaked at $60.6M in Q2 2021. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- AMP Capital Investors reported no remaining Eli Lilly position as of Q2 2022 after selling out during the quarter.
- AMP Capital Investors sold 6,900 Eli Lilly shares in Q2 2022, an estimated $1.98M.
- AMP Capital Investors first reported a position in Eli Lilly in Q2 2013 and held it in 35 quarters.
- AMP Capital Investors's Eli Lilly position peaked at $60.6M in Q2 2021.
- 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on AMP Capital Investors's 13F filing for Q2 2022.